Piper Sandler Companies has appointed Aamer Naseer as global head of life sciences outsourcing and B2B medical technology.

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the appointment of Aamer Naseer to global head of life sciences outsourcing and B2B med tech.

"Aamer has built deep relationships across the life sciences ecosystem and has a strong track record of advising private equity firms, public companies and founders/entrepreneurs. His leadership, sector expertise and commitment to our clients position us exceptionally well to continue expanding our capabilities in this important and evolving space," said J.P. Peltier, global co-head of investment banking and capital markets.

"I'm honored to step into this new role and excited to work alongside our talented team. This sector continues to evolve and consolidate rapidly and our clients are navigating increasingly dynamic strategic decisions. I'm looking forward to supporting our clients and driving meaningful outcomes across the life sciences outsourcing and the B2B med tech landscape," said Naseer.

Over the past 25 years, Naseer has worked with a variety of public and private companies including medical manufacturing businesses and outsourcing service providers to med tech OEMs as well as orthopedic, cardiology, dental, aesthetic and ophthalmology companies in the medical device sector.

http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall 
not be liable for errors or delays in the content, or for any actions 
taken in reliance thereon
COMTEX_477832144/2227/2026-04-23T18:31:41